These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 22169755)

  • 1. Aromatase, breast cancer and obesity: a complex interaction.
    Bulun SE; Chen D; Moy I; Brooks DC; Zhao H
    Trends Endocrinol Metab; 2012 Feb; 23(2):83-9. PubMed ID: 22169755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer.
    Wang X; Simpson ER; Brown KA
    J Steroid Biochem Mol Biol; 2015 Sep; 153():35-44. PubMed ID: 26209254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.
    Chen D; Reierstad S; Fang F; Bulun SE
    Mol Endocrinol; 2011 May; 25(5):767-75. PubMed ID: 21393445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen production and action.
    Nelson LR; Bulun SE
    J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S116-24. PubMed ID: 11511861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.
    Bhardwaj P; Au CC; Benito-Martin A; Ladumor H; Oshchepkova S; Moges R; Brown KA
    J Steroid Biochem Mol Biol; 2019 May; 189():161-170. PubMed ID: 30851382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
    Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
    Rubin GL; Zhao Y; Kalus AM; Simpson ER
    Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase in aging women.
    Bulun SE; Zeitoun K; Sasano H; Simpson ER
    Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
    Chen D; Reierstad S; Lin Z; Lu M; Brooks C; Li N; Innes J; Bulun SE
    Cancer Res; 2007 Sep; 67(18):8914-22. PubMed ID: 17875734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
    Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
    Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of aromatase expression in breast cancer tissue.
    Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
    Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
    Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sources of estrogen and their importance.
    Simpson ER
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):225-30. PubMed ID: 14623515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation, dysregulated metabolism and aromatase in obesity and breast cancer.
    Zahid H; Simpson ER; Brown KA
    Curr Opin Pharmacol; 2016 Dec; 31():90-96. PubMed ID: 27875786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase expression and regulation in breast and endometrial cancer.
    Zhao H; Zhou L; Shangguan AJ; Bulun SE
    J Mol Endocrinol; 2016 Jul; 57(1):R19-33. PubMed ID: 27067638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine-stimulated gene expression profile favors estradiol production in breast tumors.
    Amin SA; Huang CC; Reierstad S; Lin Z; Arbieva Z; Wiley E; Saborian H; Haynes B; Cotterill H; Dowsett M; Bulun SE
    Mol Cell Endocrinol; 2006 Jul; 253(1-2):44-55. PubMed ID: 16735089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of PARP-1, Histone H1 and SIRT-1 as New Regulators of Breast Cancer-Related Aromatase Promoter I.3/II.
    Kaiser A; Krüger T; Eiselt G; Bechler J; Kniemeyer O; Huber O; Schmidt M
    Cells; 2020 Feb; 9(2):. PubMed ID: 32059481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.
    Rajhans R; Nair HB; Nair SS; Cortez V; Ikuko K; Kirma NB; Zhou D; Holden AE; Brann DW; Chen S; Tekmal RR; Vadlamudi RK
    Mol Endocrinol; 2008 Mar; 22(3):649-64. PubMed ID: 18079323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.
    Richards JA; Petrel TA; Brueggemeier RW
    J Steroid Biochem Mol Biol; 2002 Feb; 80(2):203-12. PubMed ID: 11897504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.